
Next Generation Dx 2019 | Launch a Paradigm Shift through an Innovative Diagnostic Test
05/06/2019
0:00
11:36
Prof. Joshua Krieger from Harvard Business School shares his perspectives on some of the challenges and opportunities in commercialization of diagnostic tests and gives us a preview of his business case study on Genomic Health.
For more information, please visit https://www.NextGenerationDx.com/Commercialization-Molecular-Diagnostics
Mais episódios de "CHI Podcasts"



Não percas um episódio de “CHI Podcasts” e subscrevê-lo na aplicação GetPodcast.








